Pfizer's Yield Is Three Times Bigger. Johnson & Johnson's Dividend Has Something Pfizer Does Not

The article cautions that Pfizer’s higher dividend yield than Johnson & Johnson’s may not indicate reliable income, citing a frozen dividend, rising debt, and a multibillion-dollar write-down as risks. It provides no specific figures or market reaction.